Details
Product Name in the RMS: Bupre-HEXAL 7 Tage 5 Mikrogramm/Stunde transdermales Pflaster
MR Number: DE/H/4045/001
Date of outcome: 12.01.2016
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Other Chemical Substance Prescription Only |
Active Substances |
buprenorphine 5 µg/h |
Form | Transdermal patch |
MA Holder in the RMS |
Hexal Aktiengesellschaft Industriestrasse 25 D-83607 Holzkirchen Germany |
RMS | Germany |
Date of last change | 02.02.2021 |
ATC-Code |
N02AE01 Buprenorphine |
CMS Country | Domestic Product Name |
---|---|
Denmark | Buprenorphine "Sandoz" |
Finland | |
Ireland | |
Netherlands | Buprenorfine Sandoz 5 microgram/uur, pleister voor transdermaal gebruik |
Norway | Bugnanto |
Portugal | |
Spain | |
Sweden | |
United Kingdom | BupreHexal 7 Tage Matrixpf. 5 Mikrogramm/Stunde transdermales Pflaster |
Documents | |
---|---|
PAR: | DE_H_4045_001_PAR.pdf (22.05.2017) |
Finalised Product Information: | DE_H_4045_001_FinalPI_1of2.pdf (07.11.2018) |
Finalised Product Information: | DE_H_4045_001_FinalPI_2of2.pdf (07.11.2018) |